GMCA 1635 Research into Emerging Drug Trends across Greater Manchester

The Greater Manchester Combined Authority (GMCA) is actively seeking bids for the project titled "GMCA 1635 Research into Emerging Drug Trends across Greater Manchester," focusing on analytical testing and investigation of emerging drug trends in the region. This service is part of their commitment to maintaining a comprehensive Drugs Intelligence System. The procurement process is at the tender stage, with submissions required via The Chest by 12 January 2026.

The initiative is valued at approximately £393,726, potentially extending to £472,471, and falls under the industry category of research and development services, health and social work services, and community services. Located in the UKD3 region, GMCA represents a sub-central public authority engaged in the open procedure procurement method, compliant with the UK's broader procurement framework. This tender offers significant opportunities for growth to businesses capable of providing comprehensive research and analytical services related to drug trends and public health.

Companies specializing in research and development, particularly those with expertise in social work or community services, are ideally suited to this opportunity. Small and medium-sized enterprises and VCSEs are encouraged to apply, leveraging their potential to contribute to public health innovations. Success in this tender could enhance the business profile and expand capabilities in public service research within Greater Manchester and beyond.